Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 28, 2018

Primary Completion Date

September 21, 2018

Study Completion Date

September 21, 2018

Conditions
Stress Urinary Incontinence
Interventions
DRUG

GTx-024

Study drug is an opaque, white to off-white, size 5, oval Softgel capsule containing the active ingredient GTx-024. Subjects will be required to take one 3 mg Softgel capsule per day.

Trial Locations (46)

10016

Manhattan Medical Research Practice PLLC, New York

11530

Accumed Research Associates, Garden City

12601

Premier Medical Group, Poughkeepsie

14224

Circuit Clinical, West Seneca

19004

Urologic Consultants of Southeastern PA LLP, Bala-Cynwyd

19104

University of Pennsylvania Health System, Philadelphia

21076

Chesapeake Urology Associates PA, Hanover

23462

Urology of Virginia, Virginia Beach

28207

American Health Research Inc, Charlotte

28562

Eastern Carolina Women's, New Bern

29464

Coastal Carolina Research Center, Mt. Pleasant

30328

Mount Vernon Clinical Research LLC, Sandy Springs

32720

Midland Florida Clinical Research Center LLC, DeLand

33060

Clinical Research Center of Florida, Pompano Beach

33180

So. Florida Medical Research, Aventura

33186

Medical Research of Florida, Miami

33761

Tampa Bay Medical Research Inc, Clearwater

35209

Urology Center of Alabama, Homewood

36608

Coastal Clinical Research Inc, Mobile

38305

The Jackson Clinic, Jackson

43213

Aventiv Research, Columbus

45212

The Urology Group, Cincinnati

47130

First Urology PSC, Jeffersonville

48073

William Beaumont Hospital Urology Research, Royal Oak

49009

Beyer Research, Kalamazoo

50266

Iowa Clinic, West Des Moines

68510

Women's Clinic of Lincoln, Lincoln

70115

DelRicht Clinical Research, LLC, New Orleans

71106

Regional Urology, Shreveport

75231

Urology Clinics of North Texas, Dallas

78229

Urology San Antonio Research PA, San Antonio

78758

Elligo - Austin Area OBGYN, Austin

80113

Urology Associates Research, Englewood

80220

Genitourinary Surgical Consultants, Denver

83221

Clinical Research Prime, Idaho Falls

83642

Idaho Urologic Institue, Meridian

84041

Synexus Clinical Research Advantage, Inc. - Wasatch Peak Family Practice, Layton

89144

Sheldon J Freedman MD Ltd, Las Vegas

98105

Seattle Womens: Health, Research, Gynocology, Seattle

99503

Alaska Clinical Research Center, Anchorage

06032

Women's Health Specialty Care, Farmington

06320

Coastal Connecticut Research, LLC, New London

02131

Boston Clinical Trials, Boston

02472

Bay State clinical Trials, Watertown

08837

Premier Urology Group, LL, Edison

08648

Lawrence Obs Gyn clinical Research, Lawrenceville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GTx

INDUSTRY

NCT03566290 - Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence | Biotech Hunter | Biotech Hunter